Patients suffering from lung cancer can breathe a sigh of relief because the scientists have finally identified a new drug which is anticipated to stop the small cell lung tumors from spreading. This drug displayed a capacity to kill all cancerous cells of the lungs when tested in mice. It is now to be tested on patients.
Lung cancers are known to spread rapidly and, in most cases, have a very poor prognosis. Chemotherapy along with radiation therapy helps in reduction of the growth of cells, but they multiply very rapidly and finally become resistant to any further treatment. FGF – 2, which is a growth hormone, speeds up the division of cancer cells and makes them resistant to chemotherapy.
Now researchers have found a new drug, PD173074 which helps in blocking FGF-2 from multiplying further. It has been reported that this drug can be taken as a pill and intravenous drip might not be necessary.
Researchers are predicting that if this new drug proves to be successful in human beings, it will be a blessing for patients suffering from lung cancer because they have a chance of living longer ranging between 5 to 10 years.
Related News
- Clinical Trial for Experimental Lung Cancer Drug Ended by Pfizer
- Promising Results Exhibited by NZ Lung Cancer Medicine
- Lung-cancer risk Less For Non-Smokers and Soy Consumers
- Cancer Drug 'Trichostatin A' Effective in Preventing Premature Birth - Scientists
- FDA Approves Istodax for Treatment of Cutaneous T-cell lymphoma
- Addition of Neratinib to Taxol in Women with Metastatic Breast Cancer Shows Positive Results - Researchers
- Tumors in Women with Breast Cancer Shrunk with Use of T-DM1
Good News USA
Entertainment News
- CBS chief: NBC’s failed Leno experiment brought increased ad revenue for CBS
- Walt Disney unveils its new ‘KeyChest’ “enabling technology”
- Rotten Tomatoes Sold to Flixster by News Corp
- NBC Latest Season of “Celebrity Apprentice” to be on Air by 14 March
- Viewing Costs and Choices Threatened by Cable TV Standoffs
